Prescient Therapeutics: Novel Treatments for a Range of Cancers

Feb. 24, 2016
Prescient Therapeutics (“PTX,” “Prescient,” or the “Company”) is a clinical stage oncology company developing novel compounds that show great promise as ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market